Analyst
UTIPF
Equibles does not estimate personal net worth.
Dara Ganatra is recorded as Analyst at UTIPF. Dara Ganatra has spoken on 3 earnings calls across 3 companies, most recently for Lupin Limited on November 4, 2026. Those appearances were for Lupin Limited, Max Healthcare Institute Limited and Sun Pharmaceutical Industries Limited. The companies whose calls Dara Ganatra spoke on are classified in the Healthcare sector.
“So my question was on the gross margin front, sir. So as Cholwapton and Mirabrigron being the exclusive products, as they have come off in this quarter, and we are clearly seeing that with the decline in the revenues, the same impact has not been reflected on the gross margin side.”
“My question is, largely on this trade margin cap that has come out, so what I wanted to understand is, what is the kind of share of pharmacy revenue and EBITDA, share of pharmacy in both revenue and EBITDA, and within that, how much would be medical oncology?”
“So my question was more on the India business growth. So, we have seen in the last two years the volume growth is hardly anything, and we are now seeing a 6% kind of a volume growth.”
UTIPF
Analyst
Transcript header (unverified)
Lupin Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Max Healthcare Institute Limited
Medical Care Facilities · Healthcare
Sun Pharmaceutical Industries Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Lupin Limited
Earnings Call for the Quarter Ended September 30, 2026
Max Healthcare Institute Limited
Earnings Call
Sun Pharmaceutical Industries Limited
